摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(7E)-3,4,5,6-tetrahydro-2H-oxocin-8-yl] 2-methylprop-2-enoate

中文名称
——
中文别名
——
英文名称
[(7E)-3,4,5,6-tetrahydro-2H-oxocin-8-yl] 2-methylprop-2-enoate
英文别名
——
[(7E)-3,4,5,6-tetrahydro-2H-oxocin-8-yl] 2-methylprop-2-enoate化学式
CAS
——
化学式
C11H16O3
mdl
——
分子量
196.24
InChiKey
XSYJREZGBLTHKD-JXMROGBWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    14
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    35.5
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • SYMMETRIC HYPERBRANCHED TYPE SILICONE-MODIFIED POLYMERIZABLE COMPOUND, AND ITS MODULARIZED PREPARATION METHOD
    申请人:SHIN-ETSU CHEMICAL CO., LTD.
    公开号:US20160039848A1
    公开(公告)日:2016-02-11
    A symmetric hyperbranched type silicone-modified polymerizable compound contains a compound represented by the following general formula (1). A hyperbranched type silicone-modified polymerizable compound has flexibility at the branched skeleton itself than the conventional ones, and reactivity of a polymerizable functional group is good and it is positionally and sterically symmetric, while it has a highly branched structure having siloxane chains. [(R A R B ) 2 CHOCH 2 ] 2 CHOR C c R D (1) R A represents a monovalent linear, branched or cyclic siloxane chain; R B represents a divalent hydrocarbonylene methylene ether group represented by —CH 2 CR b1 R b2 (CR b3 R b4 ) n1 OCH 2 —, each of R b1 , R b2 , R b3 and R b4 may be the same or different from each other and represents a hydrogen atom or a linear, branched or cyclic hydrocarbon group having 1 to 10 carbon atoms which may be bonded to each other, “n1” represents an integer selected from 0 to 10; R C , a divalent linking group; “c”, 0 or 1; and R D , an unsaturated polymerizable functional group.
    一种对称的超支化改性可聚合化合物,包含以下通式(1)所代表的化合物。超支化改性可聚合化合物具有比传统化合物更灵活的分支骨架,具有良好的聚合官能团反应性,并且在位置上和立体上对称,同时具有高度支化的硅氧烷链结构。 [(RARB)2CHOCH2]2CHORCcRD(1) 其中,RA代表单价线性、支化或环状硅氧烷链;RB代表由—CH2CRb1Rb2(CRb3Rb4)n1OCH2—表示的二价烃基亚甲基醚基团,其中,Rb1、Rb2、Rb3和Rb4中的每一个可以相同也可以不同,表示氢原子或具有1至10个碳原子的线性、支化或环状烃基,这些烃基可以相互连接,“n1”表示从0到10的整数;RC表示二价连接基团,“c”为0或1;RD表示不饱和聚合官能团。
  • SYMMETRICAL HYPERBRANCHED SILICONE-MODIFIED POLYMERIZABLE COMPOUND AND PREPARATION METHOD MODULARIZING SAME
    申请人:Shin-Etsu Chemical Co., Ltd.
    公开号:EP2975044A1
    公开(公告)日:2016-01-20
    The present invention relates to a symmetric hyperbranched type silicone-modified polymerizable compound containing a compound represented by the following general formula (1). There can be provided a hyperbranched type silicone-modified polymerizable compound which has flexibility at the branched skeleton itself than the conventional ones, as well as reactivity of a polymerizable functional group is good and it is positionally and sterically symmetric, while it has a highly branched structure having siloxane chains.         [(RARB)2CHOCH2]2CHORCcRD     (1) wherein RA represents a monovalent linear, branched or cyclic siloxane chain; RB represents a divalent hydrocarbonylene methylene ether group represented by -CH2CRb1Rb2(CRb3Rb4)n1OCH2-, each of Rb1, Rb2, Rb3 and Rb4 may be the same or different from each other and represents a hydrogen atom or a linear, branched or cyclic hydrocarbon group having 1 to 10 carbon atoms which may be bonded to each other, "n1" represents an integer selected from 0 to 10; RC represents a divalent linking group; "c" represents 0 or 1; and RD represents an unsaturated polymerizable functional group.
    本发明涉及一种对称超支化型改性可聚合化合物,其中含有由下式(1)表示的化合物。本发明提供了一种超支化型改性可聚合化合物,它的支化骨架本身比传统的具有柔韧性,可聚合官能团的反应活性好,位置和立体对称,同时具有硅氧烷链的高支化结构。 [(RARB)2CHOCH2]2CHORCcRD (1) 其中 RA 代表一价线性、支链或环状硅氧烷链;RB 代表二价烃烯亚甲基醚基团,由-CH2CRb1Rb2(CRb3Rb4)n1OCH2-表示,Rb1、Rb2、Rb3 和 Rb4 中的每一个可以彼此相同或不同,并代表氢原子或具有 1 至 10 个碳原子的线性、支链或环状烃基,这些烃基可以相互键合,"n1 "代表选自 0 至 10 的整数;RC 代表二价连接基团;"c "代表 0 或 1;以及 RD 代表不饱和可聚合官能团。
  • Symmetric hyperbranched silicone-modified polymerizable compound and modularized manufacturing method thereof
    申请人:Shin-Etsu Chemical Co., Ltd.
    公开号:EP2778169B1
    公开(公告)日:2016-12-07
  • US20140275599A1
    申请人:——
    公开号:US20140275599A1
    公开(公告)日:2014-09-18
  • US9233991B2
    申请人:——
    公开号:US9233991B2
    公开(公告)日:2016-01-12
查看更多

同类化合物

胰岛素原(cattle),29-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-59-[N6-[[2-(甲磺酰)乙氧基]羰基]-L-赖氨酸]-(9CI) 十氢-2,7-苯并二氧杂环癸烷-3,6-二酮 二环<3.3.0>-2-氧杂-5-(2-丙烯基)-1-辛烯 乙烯邻苯二甲酸酯 [(E,1R)-1-[(2R,4Z,7S,8R)-7-溴-8-乙基-3,6,7,8-四氢-2H-氧杂环辛三烯-2-基]己-3-烯-5-炔基]乙酸酯 [(2R,3S,4E,6R,7S)-6,7-二羟基-2-甲基-10-氧代-2,3,6,7,8,9-六氢氧杂环辛三烯-3-基] (E)-丁-2-烯酸酯 6,7-二氢-5aH-氧杂环丁烷并[3,2-d][1,3]苯并二氧戊环 5-氧杂-10-氮杂三环[5.3.1.03,8]十一碳-1(10),2,6,8-四烯 3-氧杂二环[3.3.1]壬-6-烯-9-酮 3,4,5,6-四氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 17-苯基-18,19,20-三去甲-前列腺素F2-alpha1,15-内酯 10-(乙酰氧基)-4,5,6,7-四氢-2H-1-苯并氧杂环辛三烯-2,8(3H)-二酮 1-(2,3,4,5-四氢-1,6-苯并二噁辛英-8-基)丙烷-1-酮 1,2-环己烷二甲酸1-甲基-1,2-乙二基酯 (S)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (R)-5-烯丙基-2-氧杂双环[3.3.0]辛-8-烯 (7Z)-2-(3-溴丙-1,2-二烯基)-5-(1-溴丙基)-3,3a,5,6,9,9a-六氢-2H-呋喃并[3,2-b]氧杂环辛三烯 (7E)-4,7-二羟基-10-甲基-3,4,5,6,9,10-六氢氧杂环辛三烯-2-酮 (6Z)-10-甲基-3,4,5,8,9,10-六氢-2H-氧杂环辛三烯-2-酮 (5Z,8S)-3-氯-2-[(E)-戊-2-烯-4-炔基]-8-[(E)-丙-1-烯基]-3,4,7,8-四氢-2H-氧杂环辛三烯 (4Z)-3,6-二氢-2,7-苯并二氧杂环癸烷e-1,8-二酮 (4S,5Z,7S,8S,10R)-4,7,8-三羟基-10-甲基-3,4,7,8,9,10-六氢氧杂环辛三烯-2-酮 (4R,5R,6Z,8S,10R)-4,5,8-三羟基-10-甲基-3,4,5,8,9,10-六氢氧杂环辛三烯-2-酮 (2R,5Z)-8a-[(R)-1-溴丙基]-3a-氯-3,4,7,8-四氢-2a-[(Z)-2-戊烯-4-炔基]-2H-氧杂环辛三烯 8-Chlor-1,6-benzodioxocin 2,2,6-Trifluoro-4-phenyl-3-trifluoromethyl-2H-pyran 2,3,4,5,6,7-Hexahydro-1-benzoxonin aspinolide C 4-deutero-4,5-dihydro-2H-benzo[b]oxocin-6(3H)-one 3-Carbethoxy-4-bromo-5,6-dihydro-2-pyron (E,8S,13S)-8,13-diisopropyl-5,8,9,12,13,16-hexahydro-6,15-dioxa-benzocyclotetradecene-7,14-dione (1S,7Z,10R,11S)-11-t-butyldimethylsolyloxy-4-oxabicyclo[8.3.0]tridec-7-en-3-one (Z)-2-Methyl-3a,4,5,6,7,9a-hexahydro-cycloocta[b]furan-3-carboxylic acid ethyl ester (5R,8S,9R,10S,E)-5,8,9-trihydroxy-10-methyl-3,4,5,8,9,10-hexahydro-2H-oxecin-2-one 19,21-Dimethyl-4,15-dioxa-bicyclo[16.2.2]docosa-1(21),18(22),19-triene-3,16-dione (1S,4aR,8aS)-1,4,4a,8a-Tetrahydro-naphthalen-1-ol 5-methyl-2-oxo-2H-cyclohepta[b]furan-3-carboxylic acid methyl ester trans,trans-2,3;10,11-Dibenzo-1,4,9,12-tetraoxa-cyclohexadecatetraen-(2,6,10,14) 1-C-(4-O-acetyl-2,3,6-trideoxy-β-L-erytro-hex-2-en-pyranosyl)-3-bromopentane 2,2,2-Trichloro-acetimidic acid (2S,3S,6R)-2-methoxy-6-methyl-3,6-dihydro-2H-pyran-3-yl ester 1-C-(4-O-acetyl-2,3,6-trideoxy-α-L-erytro-hex-2-en-pyranosyl)-5-bromopentane (3,4-dihydro-1H-2-benzopyran-7-yl)methanesulfonylchloride methyl 2,3-C-(2-butene-1,4-diyl)-2,3-dideoxy-α,β-D-talofuranoside 3-oxobicyclo<7.3.1>-trideca-1(12),9(10)-diene-(ZZ)-12-carboxylic acid (3aS,5S,6R,8aR)-6-Hydroxy-5-methyl-3,3a,4,5,6,8a-hexahydro-cyclohepta[b]furan-2-one (Z)-3-butyl-6,7,8,9-tetrahydrooxonin-2(5H)-one 3,6-dihydro-4-methyl-2H-1-benzoxocine 18,20-Dimethyl-4,14-dioxa-bicyclo[15.2.2]henicosa-1(20),17(21),18-triene-3,15-dione 3-butyl-5,6,7,8,9,10-hexahydro-2H-oxecin-2-one